More than four years after the new Penske Truck Leasing (PTL) facility was formally proposed to the township, the completed project is finally opening.
Dave is an award-winning business reporter who has authored over 200 articles for New Brunswick Today.
In Setback for J&J’s COVID-19 Vaccine, Federal Government Pauses Distribution
The Acting FDA Commissioner told reporters that half a dozen “cases of a rare and severe type of blood clot” had occurred nationwide in women who were administered the Johnson & Johnson COVID-19 vaccine.
Pending Federal Approval, J&J’s COVID-19 Vaccine Could Start Shipping in March
Widely viewed as potentially game-changing, a single-dose COVID-19 vaccine produced by Johnson & Johnson is on track to receive federal approval within weeks.
County Grants 51 Small Businesses Federal Funds
Using the federal CDBG funding authorized by the CARES Act, the county awarded $1,062,260 in grants for job retention and creation to local establishments with no more than ten employees and net incomes of $100,000 or less per year.
Advocates Call on Healthcare Giant J&J to Stop Selling Baby Powder
In May, the New Brunswick-based corporation said it “will wind down the commercialization of talc-based Baby Powder in the US and Canada in the coming months,” adding that “existing inventory will continue to be sold through retailers until it runs out.” But that’s not enough, says “Black Women for Wellness,” one of the many advocacy groups pushing for J&J to stop selling its baby powder worldwide.
Biopharma Leaders Including J&J Unite on Vaccine Safety Pledge
NEW BRUNSWICK, NJ—Nine drug company CEO’s including Johnson & Johnson’s Alex Gorsky signed a September 8 pledge to continue making the safety of vaccinated individuals the top priority as they develop the first COVID-19 vaccines, according to a media release. In the pledge, consumer health products and pharmaceutical giant J&J said that “the safety and well-being […]
New Brunswick’s J&J to Buy Boston Area Pharma Company For $6.5 Billion
Johnson & Johnson (J&J) said on August 19 it agreed to purchase drugmaker Momenta Pharmaceuticals Inc. for about $6.5 billion.